| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | Aug 13, 2025 | Caris Life Sciences, Inc. | Director | Sell | 17.5 | -139,517 | -20.91% | ✗ | $4.2M |
| May 16, 2025 | May 16, 2025 | EXELIXIS, INC. | Director | Sell | 20.0 | -20,634 | -10.88% | ✗ | $949K |
| Feb 14, 2025 | Feb 19, 2025 | EXELIXIS, INC. | Director | Sell | 20.0 | -15,874 | -8.59% | ✗ | $551.5K |
| Nov 1, 2024 | Nov 5, 2024 | EXELIXIS, INC. | Director | Sell | 17.5 | -30,000 | -15.07% | ✗ | $1M |
| Aug 8, 2024 | Aug 12, 2024 | EXELIXIS, INC. | Director | Sell | 20.0 | -33,725 | -14.49% | ✗ | $906.9K |
| May 21, 2024 | May 22, 2024 | EXELIXIS, INC. | Director | Sell | 22.5 | -11,686 | -5.18% | ✗ | $244.9K |
| Nov 29, 2022 | Dec 1, 2022 | EXELIXIS, INC. | Director | Sell | 20.0 | -40,000 | -17.15% | ✗ | $667.2K |
| May 14, 2021 | May 17, 2021 | EXELIXIS, INC. | Director | Sell | 17.5 | -40,802 | -20.61% | ✗ | $1M |
| May 7, 2020 | May 8, 2020 | EXELIXIS, INC. | Director | Sell | 20.0 | -30,000 | -21.01% | ✗ | $768.3K |
| Aug 16, 2019 | Aug 19, 2019 | EXELIXIS, INC. | Director | Sell | 20.0 | -25,000 | -18.14% | ✗ | $512.5K |
| Aug 9, 2019 | Aug 9, 2019 | EXELIXIS, INC. | Director | Sell | 20.0 | -20,000 | -15.06% | ✗ | $412K |
| Mar 29, 2019 | Mar 29, 2019 | EXELIXIS, INC. | Director | Sell | 37.5 | -3,860 | -3.63% | ✓ | $92.2K |
| Feb 28, 2018 | Mar 2, 2018 | EXELIXIS, INC. | Director | Sell | 20.0 | -15,000 | -15.24% | ✗ | $393.9K |
| Mar 1, 2017 | Mar 3, 2017 | EXELIXIS, INC. | Director | Sell | 17.5 | -76,250 | -32.96% | ✗ | $1.7M |